丙戊酸相关药物基因遗传多态性与癫痫治疗效果关系的研究进展

doi:10.3969/j.issn.1006-6233.2023.08.034

摘要
图/表
参考文献
相关文章 (15)

[1] 李乐,陈双节,胡碎钗,等.重症监护病房儿童外伤性脑损伤后癫痫的危险因素分析[J].中国妇幼保健,2022,37(10):1871-1874.
[2] 任瑞娜,李蕊彤,唐思媛,等.microRNA基因单核苷酸多态性与丙戊酸抗癫痫疗效的相关性[J].中国临床药理学杂志,2022,38(8):763-767.
[3] 陈傲寒.丙戊酸单药治疗癫痫患者疗效的生物信息学分析[J].中风与神经疾病杂志,2021,38(8):756-759.
[4] 杨雪,王萍,潘静,等.丙戊酸浓度与单药或联用治疗门诊癫痫患者生化指标的相关性[J].中南大学学报:医学版,2020,45(7):782-789.
[5] 王方杰,王婷,杨智,等.β-氧化代谢基因多态性与癫痫患儿丙戊酸肝毒性的相关性[J].儿科药学杂志,2022,28(2):4-8.
[6] 朱彩华,刘阳,张淼,等.左乙拉西坦与卡马西平对癫痫儿童情绪行为和骨代谢脂代谢的影响[J].安徽医学,2019,40(10):115-1118.
[7] 毛玲艳,蔡旸,张倩倩,等.颞叶癫痫合并额叶运动症状对癫痫严重程度及预后的影响[J].中国临床医学,2022,29(5):731-737.
[8] 陶华,周煦,陈增强,等.颞叶癫痫患者外周血非离子通道基因甲基化水平观察[J].山东医药,2021,61(20):58-60.
[9] Korkmaz OT,Arkan S,Oncu-Kaya EM,et al.Vasoactive intestinal peptide (VIP) conducts the neuronal activity during absence seizures:GABA seems to be the main mediator of VIP[J].Neurosci Lett,2021,765(12):136268.
[10] 卢应梅.胶质细胞离子通道功能调控与癫痫药物靶标[J].中国药理学与毒理学杂志,2021,35(9):696-696.
[11] 藏春光,王剑.藤苦参介导PKCγ/GAP-43通路下调癫痫大鼠免疫细胞因子表达对神经元损伤的保护机制[J].现代医学,2022,50(3):360-365.
[12] Symonds J,Lang B,Vincent A,et al.A prospective whole Scottish population study of genetic and immune causes of epilepsy and complex febrile seizures in children under three years of age:the Genetic and Autoimmune Childhood Epilepsy (GACE) Study[J].Scott Med,2018,63(1):35-36.
[13] 徐欣,凌至培,余新光,等.脑深部电刺激治疗药物难治性癫痫:5个不同刺激靶点的长期临床效果比较[J].临床神经外科杂志,2021,18(4):404-408,413.
[14] 张祎鸣,钱若兵,傅先明,等.迷走神经刺激术治疗药物难治性癫痫的疗效分析(附110例报道)[J].中华神经外科杂志,2019,35(10):1059-1063.
[15] 温秦庆,贾健,刘亚峰.褪黑素和丙戊酸在预防偏头痛中的临床研究[J].脑与神经疾病杂志,2018,26(10):615-619.
[16] 章慧,郑东,方雅秀,等.拉莫三嗪联合丙戊酸钠治疗难治性癫痫的疗效及对患者认知功能及外周血NSE,MBP的影响[J].海南医学,2022,33(7):872-874.
[17] 张小龙,张远达,何华芬,等.丙戊酸,奥卡西平,左乙拉西坦单药治疗对学龄期癫痫患儿的疗效及骨代谢水平影响[J].中国儿童保健杂志,2020,28(3):331-334.
[18] Lopez-Garcia MA,Feria-Romero IA,Serrano H,et al.Influence of genetic variants of CYP2D6,CYP2C9,CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy[J].Pharmacol Rep,2017,69(3):504-511.
[19] 金素丽,闫会敏,武艳,等.河北省汉族精神疾病患者CYP2C19基因多态性与丙戊酸代谢的关系分析[J].河北医学,2023,29(1):97-102.
[20] 陈军,朱育昌,张惠婷.UGT1A6rs2070959基因多态性与癫痫患者VPA代谢的相关性分析[J].中国医师杂志,2018,20(10):1473-1476.
[21] Ma L,Pan Y,Sun M,et al.Catalase C-262T polymorphism is a risk factor for valproic acid-induced abnormal liver function in Chinese patients with epilepsy[J].Ther Drug Monit,2019,41(1):91-96.
[22] Chen L,Tian Q,Zhang M,et al.CPSI T1405N polymorphism,HDL cholesterol,homocysteine and renal function are risk factors of VPA induced hyperammonemia among epilepsy patients[J].Epilepsy Res,2019,154(9):139-143.
[23] Ma L,Wang Y,Chen X,et al.Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro[J].Toxicology,2020,445(12):152585.